An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center-Reference-Cited by-同舟云学术

An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center

Published:2021-03-15 Issue:6 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Fu Lingling¹²³^ORCID,Ma Jie¹²³^ORCID,Gu Hao¹²³,Ma Jingyao¹²³,Wei Yunyun¹²³,Chen Zhengping¹²³,Wu Runhui¹²³^ORCID

Affiliation:

1. Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health Beijing Key Laboratory of Pediatric Hematology Oncology Beijing China

2. National Key Discipline of Pediatrics (Capital Medical University) Beijing China

3. Key Laboratory of Major Diseases in Children Ministry of Education Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29006

Reference24 articles.

1. Management of Acute Childhood Idiopathic Thrombocytopenic Purpura according to AIEOP Consensus Guidelines: Assessment of Italian Experience

2. American Society of Hematology 2019 guidelines for immune thrombocytopenia

3. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

4. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment

5. [Clinical study of pulsed high‐dose dexamethasone treatment in 38 children with primary immune thrombocytopenic purpura];Ma J;Zhonghua Xue Ye Xue Za Zhi,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Nucleotide Polymorphisms of the HIF1A Gene are Associated With Sensitivity of Glucocorticoid Treatment in Pediatric ITP Patients;Journal of Pediatric Hematology/Oncology;2022-05-04

2. Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021);Pediatric Investigation;2022-02-21

3. Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center;European Journal of Pediatrics;2021-05-27

4. An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center;Pediatric Blood & Cancer;2021-03-15